Toronto Dominion Bank
LSBPW

Toronto Dominion Bank’s LakeShore Biopharma Warrants LSBPW Stock Holding History

Toronto Dominion Bank’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,048,320
Closed -$41.8K – 2137
2025
Q2 		$41.8K Buy
+1,048,320
New +$41K ﹤0.01% 1518

Other funds holding LSBPW

HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Toronto Dominion Bank's LSBPW Position: Q3 2025 in Review

Toronto Dominion Bank sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 1,048,320 shares — an estimated $41.8K sold.

Toronto Dominion Bank first reported a position in LSBPW in Q2 2025 and held it in 1 quarter. The position peaked at $41.8K in Q2 2025. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

  • Toronto Dominion Bank reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
  • Toronto Dominion Bank sold 1,048,320 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $41.8K.
  • Toronto Dominion Bank first reported a position in LakeShore Biopharma Warrants in Q2 2025 and held it in 1 quarter.
  • Toronto Dominion Bank's LakeShore Biopharma Warrants position peaked at $41.8K in Q2 2025.
  • 3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on Toronto Dominion Bank's 13F filing for Q3 2025, filed 14 Nov 2025.